Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kristian Møller-Helgestad

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|March 31, 2015
[Frovatriptan possibly causing acute myocardial infarction]Ole Kristian Møller-Helgestad, Anne Kjer Kaltoft, Helge Kasch
Data in Brief|October 4, 2017
Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMIRikke Hansen, Martin Frydland, Ole Kristian Møller-Helgestad, et al.
International Journal of Cardiology|November 11, 2017
Association between QRS duration on prehospital ECG and mortality in patients with suspected STEMIRikke Hansen, Martin Frydland, Ole Kristian Møller-Helgestad, et al.
Anesthesiology|August 26, 2024
Cardiovascular Effects of Increasing Positive End-expiratory Pressure in a Model of Left Ventricular Cardiogenic Shock in Female PigsOskar Kjærgaard Hørsdal, Kasper Lykke Wethelund, Nigopan Gopalasingam, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 13, 2018
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal modelOle Kristian Møller-Helgestad, Janus A Hyldebrandt, Ann Banke, et al.
European Heart Journal. Acute Cardiovascular Care|November 18, 2017
Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shockPeter Blom Jensen, Sigrun Høegholm Kann, Karsten Tange Veien, et al.
European Heart Journal. Acute Cardiovascular Care|April 29, 2017
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patientsLaust Obling, Martin Frydland, Rikke Hansen, et al.
The American Journal of Cardiology|February 7, 2018
Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy)Golnaz Sadjadieh, Thomas Engstrøm, Steffen Helqvist, et al.
Shock (Augusta, Ga.)|October 5, 2018
Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial InfarctionMartin Frydland, Jacob Eifer Møller, Sebastian Wiberg, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|March 31, 2015
[Frovatriptan possibly causing acute myocardial infarction]Ole Kristian Møller-Helgestad, Anne Kjer Kaltoft, Helge Kasch
Data in Brief|October 4, 2017
Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMIRikke Hansen, Martin Frydland, Ole Kristian Møller-Helgestad, et al.
International Journal of Cardiology|November 11, 2017
Association between QRS duration on prehospital ECG and mortality in patients with suspected STEMIRikke Hansen, Martin Frydland, Ole Kristian Møller-Helgestad, et al.
Anesthesiology|August 26, 2024
Cardiovascular Effects of Increasing Positive End-expiratory Pressure in a Model of Left Ventricular Cardiogenic Shock in Female PigsOskar Kjærgaard Hørsdal, Kasper Lykke Wethelund, Nigopan Gopalasingam, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 13, 2018
Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal modelOle Kristian Møller-Helgestad, Janus A Hyldebrandt, Ann Banke, et al.
European Heart Journal. Acute Cardiovascular Care|November 18, 2017
Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shockPeter Blom Jensen, Sigrun Høegholm Kann, Karsten Tange Veien, et al.
European Heart Journal. Acute Cardiovascular Care|April 29, 2017
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patientsLaust Obling, Martin Frydland, Rikke Hansen, et al.
The American Journal of Cardiology|February 7, 2018
Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy)Golnaz Sadjadieh, Thomas Engstrøm, Steffen Helqvist, et al.
Shock (Augusta, Ga.)|October 5, 2018
Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial InfarctionMartin Frydland, Jacob Eifer Møller, Sebastian Wiberg, et al.
Pageof 1